Experienced in Potassium-Aggravated Myotonia

Samuel I. Pascual

La Paz, MD, ES 
Experienced in Potassium-Aggravated Myotonia
La Paz, MD, ES 
OverviewLocationsClinical Research

Overview

Samuel Pascual practices in La Paz, Spain. Mr. Pascual is rated as an Experienced expert by MediFind in the treatment of Potassium-Aggravated Myotonia. His top areas of expertise are Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy Type 2.

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Potassium-Aggravated Myotonia.

Gender
Male

Locations

La Paz, MD, Spain
Other Locations
Castellana, MD 28046, Spain
Madrid, MD, Spain
UPF
Barcelona, CT, Spain
Valencia, VC, Spain
Bunyola, PM, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Enrollment Status: Completed
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: Autologous Erythrocytes, Dexamethasone Sodium Phosphate
Study Phase: Phase 3
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
View 1 Less Clinical Trial

67 Total Publications

Difficulty of administration of nusinersen in complex-column spinal muscular atrophy: New alternative technique by means of cervical intrathecal access through an Ommaya reservoir.
Difficulty of administration of nusinersen in complex-column spinal muscular atrophy: New alternative technique by means of cervical intrathecal access through an Ommaya reservoir.
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: August 05, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pascual's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 31 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile